Evidence map›Paper›PMID 36661742›Full record

ArticleCurrent oncology (Toronto, Ont.)2023

Understanding the Challenges of HPV-Based Cervical Screening: Development and Validation of HPV Testing and Self-Sampling Attitudes and Beliefs Scales.

Ovidiu Tatar, Ben Haward, Patricia Zhu, Gabrielle Griffin-Mathieu, Samara Perez, Emily McBride, Aisha K Lofters, Laurie W Smith, Marie-Hélène Mayrand, Ellen M Daley and 3 more

Open access · goldAbstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 4 countries.

Ovidiu TatarLady Davis Institute for Medical Research (LDI), Jewish General Hospital, Montreal, QC H3T 1E2, Canada.ORCID 0000-0003-1886-6390
Ben HawardLady Davis Institute for Medical Research (LDI), Jewish General Hospital, Montreal, QC H3T 1E2, Canada.ORCID 0000-0002-6119-5767
Patricia ZhuLady Davis Institute for Medical Research (LDI), Jewish General Hospital, Montreal, QC H3T 1E2, Canada.ORCID 0000-0001-6549-3668
Gabrielle Griffin-MathieuLady Davis Institute for Medical Research (LDI), Jewish General Hospital, Montreal, QC H3T 1E2, Canada.
Samara PerezLady Davis Institute for Medical Research (LDI), Jewish General Hospital, Montreal, QC H3T 1E2, Canada.
Emily McBrideInstitute of Psychiatry, Psychology & Neuroscience, King's College London, London SE5 8AF, UK.
Aisha K LoftersDepartment of Family and Community Medicine, University of Toronto, Toronto, ON M5G 1V7, Canada.
Laurie W SmithBC Cancer Agency, Vancouver, BC V5Z 1G1, Canada.
Marie-Hélène MayrandResearch Center, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC H2X 0A9, Canada.
Ellen M DaleyCollege of Public Health, University of South Florida, Tampa, FL 33612, USA.
Julia M L BrothertonMelbourne School of Population and Global Health, University of Melbourne, Melbourne, VI 3010, Australia.
Gregory D ZimetSchool of Medicine, Indiana University, Indianapolis, IN 46202, USA.
Zeev RosbergerLady Davis Institute for Medical Research (LDI), Jewish General Hospital, Montreal, QC H3T 1E2, Canada.ORCID 0000-0003-4248-1909
Jewish General Hospital · CABC Cancer Agency · CACentre Hospitalier de l’Université de Montréal · CAIndiana University – Purdue University Indianapolis · USKing's College London · GBMcGill University Health Centre · CAThe University of Melbourne · AUUniversity of South Florida · USUniversity of Toronto · CA

Funding

CIHR 165905CIHR FBD-170837
6 · The paper itself

Abstract

The disrupted introduction of the HPV-based cervical screening program in several jurisdictions has demonstrated that the attitudes and beliefs of screening-eligible persons are critically implicated in the success of program implementation (including the use of self-sampling). As no up-to-date and validated measures exist measuring attitudes and beliefs towards HPV testing and self-sampling, this study aimed to develop and validate two scales measuring these factors. In October-November 2021, cervical screening-eligible Canadians participated in a web-based survey. In total, 44 items related to HPV testing and 13 items related to HPV self-sampling attitudes and beliefs were included in the survey. For both scales, the optimal number of factors was identified using Exploratory Factor Analysis (EFA) and parallel analysis. Item Response Theory (IRT) was applied within each factor to select items. Confirmatory Factor Analysis (CFA) was used to assess model fit. After data cleaning, 1027 responses were analyzed. The HPV Testing Attitudes and Beliefs Scale (HTABS) had four factors, and twenty-two items were retained after item reduction. The HPV Self-sampling Attitudes and Beliefs Scale (HSABS) had two factors and seven items were retained. CFA showed a good model fit for both final scales. The developed scales will be a valuable resource to examine attitudes and beliefs in anticipation of, and to evaluate, HPV test-based cervical screening.

Indexed as

Papillomavirus InfectionsUterine Cervical NeoplasmsAttitudeCanadaEarly Detection of CancerFemaleHumansattitudes and beliefscervical screeningHPV self-samplingHPV testingscale developmentwomen’s health

Identifiers

PMID36661742
PMCPMC9858121
OpenAlexW4316469670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.